Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Patient demographics and baseline clinical data

From: Therapeutic hypothermia in adult patients receiving extracorporeal life support: early results of a randomized controlled study

Variable All patients n = 21 (%) Hypothermia n = 9 (%) Normothermia n = 12 (%) P-value
Demographics     
Age (years) 52.5 ± 11.0 45.9 ± 12.2 57.4 ± 7.0 0.013
Gender (male) 17 (81.0) 8 (88.9) 9 (75.0) 0.422
BSA (m2) 1.72 ± 0.18 1.71 ± 0.16 1.72 ± 0.20 0.930
Comorbidities     
Hypertension 11 (52.4) 4 (44.4) 7 (58.3) 0.528
Hyperlipidaemia 10 (47.6) 6 (50.0) 4 (44.4) 0.801
Diabetes mellitus 9 (42.9) 5 (41.7) 4 (44.4) 0.899
Renal failure (CrCl <60 ml/min) 12 (57.1) 5 (55.6) 7 (58.3) 0.899
Coronary artery disease 17 (81.0) 6 (66.7) 11 (91.7) 0.149
Peripheral vascular disease 3 (14.3) 1 (11.1) 2 (16.7) 0.719
Previous stroke 1 (4.8) 0 (0) 1 (8.3) 0.375
Atrial fibrillation 1 (4.8) 0 (0) 1 (8.3) 0.375
Smoking 12 (57.1) 6 (66.7) 6 (50.0) 0.445
LVEF (%) 23.4 ± 15.8 13.9 ± 3.6 30.3 ± 17.8 0.013
  1. Values for parametric continuous variables are expressed as mean ± standard deviation. Values for categorical variables are expressed as numbers (%)
  2. BSA body surface area, CrCl creatinine clearance, LVEF left ventricular ejection fraction